A Agilent Technologies, Inc. Common Stock
About Agilent Technologies, Inc. Common Stock Company overview from Wikipedia
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time.
Read more
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time.
From 1999 to 2014, the company produced optics (LED, laser), semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government (research) markets.
History
In 1965, Hewlett-Packard branched out into scientific equipment by acquiring F&M Scientific, maker of gas chromatographs. Agilent Technologies was created in 1999 as a spin-off of several business units of Hewlett-Packard including test & measurement, optics, instrumentation and chemical analysis, electronic components, and medical equipment product lines. The split was predicated on the difficulty of growing HP's revenue stream and on the competitive vigor of smaller, more agile competitors.
The company's launch slogan was "Innovating the HP Way", which capitalized on the strong HP corporate culture called The HP Way. The starburst logo was selected to reflect "a burst of insight" (or "spark of insight") and the name "Agilent" aimed to invoke the notion of agility as a trait of the new firm. The Agilent spin-off was accompanied by an initial public offering which raised $2.1 billion, setting a record at the time.
2000–2009
In the early 2000s, "economic uncertainty" depressed demand for Agilent's products, including slow sales of health care products to hospitals in the United States, which accounted for 60% of the company's revenue at the time. The downturn also struck sales in the communications and semiconductor markets, where orders amounting to $500 million were canceled by buyers. These poor economic conditions prompted large reductions in force with 18,500 positions cut in 2003.
In 2001, in midst of this downsizing, Agilent sold its health care and medical products organization to Philips Medical Systems, and was noted as having a valuation of about $11 billion. HP Medical Products had been the second oldest part of Hewlett-Packard, acquired in the 1950s.
In August 2005, Agilent announced the sale of its business which produced semiconductor integrated circuits (known as "chips") for consumer and industrial uses to Kohlberg Kravis Roberts and Silver Lake Partners for $2.66 billion. This move would involve termination of about 1,300 of the company's 28,000 employees. The group operated as a private company, Avago Technologies, until August 2009, when it was brought public in an IPO. After purchasing Broadcom Corporation in 2016, Avago changed its name to Broadcom Limited.
Also in August 2005, Agilent sold its 47% stake in the light-emitting diode manufacturer Lumileds to Philips for $1 billion. Lumileds originally started as Hewlett-Packard's optoelectronics division. Also in August 2005, Agilent announced a plan to divest its semiconductor test business, composed of both the system-on-chip and memory test market areas. Agilent listed the new company as Verigy on the Nasdaq in mid-2006.
2010 onwards
In 2009, Agilent announced the closure of a subsection of its Test & Measurement division. The product lines affected included the automated optical inspection, solder paste inspection, and automated X-ray products [5DX] in 2004. In 2011, the company, along with the University of California, Davis, announced that it would be establishing the "Davis Millimeter Wave Research Center". Agilent announced it would increase its life sciences engagement through the acquisition of Halo Genomics, based in Uppsala, Sweden, which was involved in next-generation sequencing technology development. On May 17, 2012, Agilent agreed to buy Dako, a Danish cancer diagnostics company, for $2.2 billion, to expand its presence in the life sciences industry.
On September 19, 2013, Agilent announced its decision to separate into two publicly traded companies: Agilent, a life sciences, diagnostics, and applied markets company, and Keysight, an electronic measurement company. The life sciences company retained the Agilent name and the electronic measurement company was called Keysight Technologies. On October 14, 2014, the company announced that it is exiting its Nuclear Magnetic Resonance business. On November 1, the formal separation of Agilent and Keysight Technologies was completed. Agilent announced it had completed the spin-off of its electronic measurement business, Keysight Technologies.
In September 2015, the company announced it would acquire Seahorse Bioscience for $235 million. On July 7, 2016, Agilent announced that it had acquired U.K. based Cobalt Light Systems, which develops and manufactures Raman spectroscopy instruments, for £40 million in cash. In December the company acquired Multiplicom N.V.
In January 2018, the company announced it would acquire Luxcel Biosciences, increasing the company's cell analysis portfolio. In May, Agilent acquired Lasergen, Inc. after the end of its two-year option on a prior investment. In the same month it acquired digital laboratory management company, Genohm, Ultra Scientific, provider of chemical standards and reference materials and Advanced Analytical Technologies, Inc. (AATI), provider of capillary electrophoresis-based molecules for $250 million in cash.
In August the company announced it would acquire glycan reagent producer, ProZyme, Inc. and South Korean instrument distributor, Young In Scientific Co. Ltd. In September Agilent acquired ACEA Biosciences for $250 million increasing the company's presence in cell analysis technologies. In August 2019, Agilent acquired US-based BioTek Instruments, a designer, manufacturer, and distributor of life science instrumentation, for $1.165 billion. On May 1, 2024, Padraig McDonnell succeeded Mike McMullen as CEO.
Products and services
Agilent serves analytical laboratories and the clinical and routine diagnostics markets with a full suite of technology platforms. These include: automation, bioreagents, FISH probes, gas and liquid chromatography, immunohistochemistry, informatics, mass spectrometry, microarrays, spectroscopy, target enrichment, and vacuum technologies.
Agilent also provides lab management services, including enterprise asset management, laboratory business intelligence, equipment management and service, software maintenance, regulatory compliance, sample preparation, genomics and cloning, GC and HPLC columns, spectrometry and spectroscopy supplies, and consumables. The company is known for investing in R&D within its own research labs and those of leading universities to advance the state of knowledge in the life sciences, diagnostics, and chemical analysis space.
In recent years, the company has advanced digital lab instrumentation and technology that improves lab workflow and overall efficiency and productivity. In 2020, Agilent introduced CrossLab Virtual Assist, a mobile app that facilities high-quality remote technical support. Agilent's digital advancements, including CrossLab Connect, have also improved lab optimization and sustainability by providing more efficient utilization of instruments, which can lower a lab's energy consumption.
Agilent is also a pioneer of the target enrichment used as part of a NGS workflow. The portfolio also includes sample prep, QA/QC instrumentation, 2100 bioanalyzers, and automation tools. In early 2023, the company announced a $725 million expansion of its nucleic acid-based therapeutics manufacturing facility in Frederick, Colorado.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
A Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
A Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Dividends Yield, payout ratio, dividend history, 5Y CAGR
| Ex-date | Amount |
|---|---|
| June 30, 2026 | $0.2550 |
| March 31, 2026 | $0.2550 |
| Jan. 6, 2026 | $0.2550 |
| Sept. 30, 2025 | $0.2480 |
| July 1, 2025 | $0.2480 |
| April 1, 2025 | $0.2480 |
| Dec. 31, 2024 | $0.2480 |
| Oct. 1, 2024 | $0.2360 |
| July 2, 2024 | $0.2360 |
| April 1, 2024 | $0.2360 |
| Dec. 29, 2023 | $0.2360 |
| Oct. 2, 2023 | $0.2250 |
| June 30, 2023 | $0.2250 |
| April 3, 2023 | $0.2250 |
| Dec. 30, 2022 | $0.2250 |
| Oct. 3, 2022 | $0.2100 |
| July 1, 2022 | $0.2100 |
| April 4, 2022 | $0.2100 |
| Jan. 3, 2022 | $0.2100 |
| Oct. 4, 2021 | $0.1940 |
A Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 8 27.6%
- Buy 14 48.3%
- Hold 7 24.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
19 analysts · 2026-08-19Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $1.49 | $1.44 | 0.05% |
| March 31, 2026 | $1.36 | $1.40 | -0.04% |
| Dec. 31, 2025 | $1.59 | $1.62 | -0.03% |
| Sept. 30, 2025 | $1.37 | $1.39 | -0.02% |
| June 30, 2025 | $1.31 | $1.29 | 0.02% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | · | $4.47B | $4.20B | $4.04B | |
| Cost of Revenue | $3.31B | $2.98B | $3.37B | $3.13B | $2.91B | $2.50B | $2.36B | · | $2.07B | $2.00B | $2.00B | |
| R&D Expense | $455M | $479M | $481M | $467M | $441M | $495M | $404M | · | $341M | $329M | $330M | |
| SG&A Expense | $1.71B | $1.57B | $1.63B | $1.64B | $1.62B | $1.50B | $1.46B | · | $1.25B | $1.25B | $1.19B | |
| Operating Expenses | $5.47B | $5.02B | $5.48B | $5.23B | $4.97B | $4.49B | $4.22B | · | $3.67B | $3.59B | $3.52B | |
| Operating Income | $1.48B | $1.49B | $1.35B | $1.62B | $1.35B | $846M | $941M | · | $807M | $615M | $522M | |
| Interest Expense | $112M | $96M | $95M | $84M | $81M | $78M | $74M | · | $79M | $72M | $66M | |
| Interest Income | $62M | $80M | $51M | $9M | $2M | $8M | $36M | · | $22M | $11M | $7M | |
| Other Non-op | $6M | $49M | $33M | $-39M | $92M | $66M | $16M | · | $53M | $-10M | $17M | |
| Pretax Income | $1.44B | $1.52B | $1.34B | $1.50B | $1.36B | $842M | $919M | · | $803M | $544M | $767M | |
| Income Tax | $132M | $232M | $99M | $250M | $150M | $123M | $-152M | · | $119M | $82M | $42M | |
| Net Income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719M | $1.07B | · | $684M | $462M | $401M | |
| EPS (Basic) | $4.59 | $4.44 | $4.22 | $4.19 | $3.98 | $2.33 | $3.41 | · | $2.12 | $1.42 | $1.20 | |
| EPS (Diluted) | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 | $2.30 | $3.37 | · | $2.10 | $1.40 | $1.20 | |
| Shares (Basic) | 284,000,000 | 290,000,000 | 294,000,000 | 299,000,000 | 304,000,000 | 309,000,000 | 314,000,000 | · | 322,000,000 | 326,000,000 | 333,000,000 | |
| Shares (Diluted) | 285,000,000 | 291,000,000 | 296,000,000 | 300,000,000 | 307,000,000 | 312,000,000 | 318,000,000 | · | 326,000,000 | 329,000,000 | 335,000,000 | |
| EBITDA | $1.77B | $1.75B | $1.62B | $1.94B | $1.67B | $1.15B | $1.18B | · | $1.05B | $861M | $775M |
Balance Sheet 29
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.79B | $1.33B | $1.59B | $1.05B | $1.48B | $1.44B | $1.38B | $2.25B | $2.68B | $2.29B | $2.00B | |
| Receivables | $1.49B | $1.32B | $1.29B | $1.41B | $1.17B | $1.04B | $930M | $800M | $724M | $631M | $606M | |
| Inventory | $1.02B | $972M | $1.03B | $1.04B | $830M | $720M | $679M | $628M | $575M | $533M | $541M | |
| Other Current Assets | $293M | $334M | $274M | $282M | $222M | $216M | $198M | $190M | $192M | $182M | $294M | |
| Current Assets | $4.59B | $3.96B | $4.19B | $3.78B | $3.80B | $3.42B | $3.19B | $3.87B | $4.17B | $3.63B | $3.69B | |
| PP&E (Net) | $2.02B | $1.78B | $1.27B | $1.10B | $945M | $845M | $850M | $822M | $757M | $639M | $604M | |
| PP&E (Gross) | $3.45B | $3.08B | $2.49B | $2.25B | $2.07B | $1.87B | $1.77B | · | $1.60B | $1.41B | $1.33B | |
| Accum. Depreciation | $1.42B | $1.30B | $1.22B | $1.15B | $1.12B | $1.03B | $925M | · | $843M | $767M | $730M | |
| Goodwill | $4.47B | $4.48B | $3.96B | $3.95B | $3.98B | $3.60B | $3.59B | $2.97B | $2.61B | $2.52B | $2.37B | |
| Intangibles | $445M | $547M | $475M | $821M | $981M | $831M | $1.11B | $491M | $361M | $416M | $445M | |
| Other Non-current Assets | $1.06B | $910M | $708M | $686M | $820M | $776M | $611M | $332M | $394M | $452M | $292M | |
| Total Assets | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B | $9.63B | $9.45B | $8.56B | $8.43B | $7.79B | $7.48B | |
| Accounts Payable | $570M | $540M | $418M | $580M | $446M | $354M | $354M | $340M | $305M | $257M | $279M | |
| Short-term Debt | $304M | $45M | $0 | $36M | $0 | $75M | $616M | · | $210M | $0 | $0 | |
| Current Liabilities | $2.35B | $1.90B | $1.60B | $1.86B | $1.71B | $1.47B | $2.08B | $1.16B | $1.26B | $945M | $976M | |
| Capital Leases | $145M | $142M | $118M | $101M | $130M | $127M | $5M | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $31M | · | $77M | $65M | $96M | |
| Other Non-current Liabilities | $463M | $578M | $477M | $536M | $659M | $614M | $473M | $763M | $293M | $339M | $414M | |
| Total Liabilities | $5.99B | $5.95B | $4.92B | $5.23B | $5.32B | $4.75B | $4.70B | $3.96B | $3.59B | $3.55B | $3.31B | |
| Long-term Debt | $3.05B | $3.35B | $2.73B | $2.73B | $2.73B | $2.28B | $1.79B | · | $1.79B | $1.89B | $1.60B | |
| Total Debt | $304M | $45M | $0 | $36M | $2.73B | $2.36B | $2.41B | · | $2.01B | $1.91B | $1.66B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $6M | $6M | |
| Paid-in Capital | $5.58B | $5.45B | $5.39B | $5.33B | $5.32B | $5.31B | $5.28B | $5.31B | $5.30B | $9.16B | $9.04B | |
| Retained Earnings | $1.39B | $750M | $782M | $324M | $348M | $81M | $-18M | $-303M | $-126M | $6.09B | $5.58B | |
| Treasury Stock | · | · | · | · | · | · | · | · | $0 | $10.51B | $10.07B | |
| AOCI | $-226M | $-305M | $-327M | $-347M | $-282M | $-522M | $-514M | $-415M | $-346M | $-503M | $-391M | |
| Stockholders' Equity | $6.74B | $5.90B | $5.84B | $5.30B | $5.39B | $4.87B | $4.75B | $4.59B | $4.83B | $4.24B | $4.17B | |
| Liabilities + Equity | $12.73B | $11.85B | $10.76B | $10.53B | $10.71B | $9.63B | $9.45B | $8.56B | $8.43B | $7.79B | $7.48B | |
| Shares Outstanding | 283,054,377 | 285,193,011 | 292,123,241 | 295,259,092 | 302,000,000 | 306,000,000 | 309,000,000 | · | 322,000,000 | 614,000,000 | 611,000,000 |
Cash Flow 19
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $288M | $257M | $271M | $317M | $321M | $308M | $238M | · | $212M | $246M | $253M | |
| Stock-based Comp | $128M | $129M | $111M | $125M | $110M | $83M | $72M | · | $60M | $58M | $54M | |
| Deferred Tax | $-130M | $-64M | $-56M | $8M | $14M | $29M | $-255M | · | $102M | $3M | $70M | |
| Amort. of Intangibles | $105M | $105M | $140M | $192M | $195M | $186M | $128M | · | $120M | $154M | $158M | |
| Restructuring | $82M | $76M | $46M | · | · | · | · | · | · | · | $6M | |
| Other Non-cash | $-30M | $140M | $206M | $-392M | $-170M | $-218M | $-105M | · | $-169M | $24M | $-287M | |
| Operating Cash Flow | $1.56B | $1.75B | $1.77B | $1.31B | $1.49B | $921M | $1.02B | · | $889M | $793M | $512M | |
| CapEx | $407M | $378M | $298M | $291M | $188M | $119M | $155M | · | $176M | $139M | $98M | |
| Investing Cash Flow | $-394M | $-1.26B | $-310M | $-338M | $-749M | $-147M | $-1.59B | · | $-304M | $-238M | $-400M | |
| Debt Issued | $4M | $1.20B | $0 | $600M | $848M | · | · | · | · | · | · | |
| Net Debt Issued | $1M | $597M | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $425M | $1.15B | $575M | $1.14B | $788M | $469M | $723M | · | $194M | $434M | $267M | |
| Net Stock Activity | $-425M | $-1.15B | $-575M | $-1.14B | $-788M | $-469M | $-723M | · | $-194M | $-434M | $-267M | |
| Dividends Paid | $282M | $274M | $265M | $250M | $236M | $222M | $206M | · | $170M | $150M | $133M | |
| Financing Cash Flow | $-715M | $-752M | $-930M | $-1.37B | $-696M | $-717M | $-299M | · | $-202M | $-268M | $-1.09B | |
| Net Change in Cash | $459M | $-261M | $537M | $-434M | $43M | $59M | $-866M | · | $391M | $286M | $-1.02B | |
| Taxes Paid | $318M | $314M | $199M | $279M | $211M | $361M | $159M | · | · | · | · | |
| Free Cash Flow | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B | $802M | $866M | · | $713M | $654M | $393M | |
| Levered FCF | $1.05B | $1.29B | $1.39B | $951M | $1.22B | $735M | $780M | · | $644M | $589M | $331M |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% | 15.8% | 18.2% | · | 18.8% | 14.6% | 12.9% | |
| Net Margin | 18.8% | 19.8% | 18.1% | 18.3% | 19.1% | 13.5% | 20.7% | · | 15.3% | 11.0% | 9.9% | |
| Pretax Margin | 20.6% | 23.4% | 19.6% | 22.0% | 21.5% | 15.8% | 17.8% | · | 21.8% | 20.4% | 19.0% | |
| EBITDA Margin | 25.4% | 26.8% | 23.7% | 28.3% | 26.4% | 21.6% | 22.8% | · | 23.5% | 20.5% | 19.2% | |
| ROA | 10.6% | 11.4% | 11.7% | 11.8% | 11.9% | 7.5% | 11.9% | · | 8.4% | 6.0% | 4.4% | |
| ROE | 20.6% | 21.9% | 22.2% | 23.4% | 23.6% | 14.9% | 22.9% | · | 15.1% | 11.0% | 8.5% | |
| ROIC | 19.1% | 21.2% | 21.4% | 25.3% | 14.8% | 10.0% | 15.3% | · | 10.8% | 9.0% | 8.5% |
Liquidity & Solvency 5
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.1 | 2.6 | 2.0 | 2.2 | 2.3 | 1.5 | · | 3.3 | 3.8 | 3.8 | |
| Quick Ratio | 1.4 | 1.4 | 1.8 | 1.3 | 1.6 | 1.7 | 1.1 | · | 2.7 | 3.1 | 2.7 | |
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | |
| LT Debt / Equity | · | · | · | · | 0.5 | 0.5 | 0.4 | · | 0.4 | 0.5 | 0.4 | |
| Interest Coverage | 13.2 | 15.5 | 14.2 | 19.3 | 16.6 | 10.8 | 12.7 | · | 10.6 | 8.5 | 7.9 |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.4 | |
| Inventory Turnover | 3.3 | 3.0 | 3.3 | 3.3 | 3.8 | 3.6 | 3.6 | · | 3.7 | 3.7 | 3.6 | |
| Receivables Turnover | 4.9 | 5.0 | 5.1 | 5.3 | 5.7 | 5.4 | 6.0 | · | 6.6 | 6.8 | 6.6 |
Growth Rates 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.7% | -4.7% | -0.22% | 8.4% | 18.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.48% | 1.0% | 8.6% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 3.2% | 5.7% | 0.24% | 6.1% | 71.3% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 3.0% | 4.0% | 22.1% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 14.7% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 1.1% | 4.0% | -1.1% | 3.6% | 68.3% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 1.3% | 2.1% | 19.9% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 4.9% | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B | $5.34B | $5.16B | · | $4.47B | $4.20B | $4.04B | |
| Net Income TTM | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B | $719M | $1.07B | · | $684M | $462M | $401M | |
| Market Cap | $41.43B | $37.16B | $30.20B | $40.81B | $47.56B | $31.24B | · | · | · | · | · | |
| Enterprise Value | $39.94B | $35.88B | $28.61B | $39.80B | $48.81B | $32.16B | · | · | · | · | · | |
| P/E | 32.0 | 29.4 | 24.7 | 33.1 | 40.0 | 44.4 | 22.5 | · | 32.4 | 31.1 | 31.5 | |
| P/S | 6.0 | 5.7 | 4.4 | 6.0 | 7.5 | 5.9 | · | · | · | · | · | |
| P/B | 6.1 | 6.3 | 5.2 | 7.7 | 8.8 | 6.4 | · | · | · | · | · | |
| P / Tangible Book | 22.7 | 42.5 | 21.4 | 76.7 | 109.8 | 71.0 | · | · | · | · | · | |
| P / Cash Flow | 26.6 | 21.2 | 17.0 | 31.1 | 32.0 | 33.9 | · | · | · | · | · | |
| P / FCF | 36.0 | 27.1 | 20.5 | 40.0 | 36.7 | 39.0 | · | · | · | · | · | |
| EV / EBITDA | 22.6 | 20.6 | 17.6 | 20.6 | 29.3 | 27.9 | · | · | · | · | · | |
| EV / FCF | 34.7 | 26.1 | 19.4 | 39.0 | 37.6 | 40.1 | · | · | · | · | · | |
| EV / Revenue | 5.7 | 5.5 | 4.2 | 5.8 | 7.7 | 6.0 | · | · | · | · | · | |
| Dividend Yield | 0.68% | 0.74% | 0.88% | 0.61% | 0.50% | 0.71% | · | · | · | · | · | |
| Earnings Yield | 3.1% | 3.4% | 4.0% | 3.0% | 2.5% | 2.2% | 4.5% | · | 3.1% | 3.2% | 3.2% | |
| Payout Ratio | 21.6% | 21.3% | 21.4% | 19.9% | 19.5% | 30.9% | 19.2% | · | 24.9% | 32.5% | 33.2% | |
| Annual Payout | $282M | $274M | $265M | $250M | $236M | $222M | $206M | · | $170M | $150M | $133M |
Income Statement 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.83B | $1.80B | $1.86B | $1.74B | $1.67B | $1.68B | $1.70B | $1.58B | $1.57B | $1.66B | $1.69B | $1.67B | $1.72B | $1.76B | $1.85B | $1.72B | |
| Cost of Revenue | $845M | $852M | $871M | $850M | $802M | $782M | $785M | $723M | $717M | $750M | $773M | $1.01B | $793M | $788M | $837M | $779M | |
| R&D Expense | $126M | $117M | $119M | $111M | $112M | $113M | $111M | $127M | $113M | $128M | $114M | $118M | $126M | $123M | $119M | $116M | |
| SG&A Expense | $465M | $476M | $428M | $417M | $454M | $410M | $397M | $395M | $380M | $396M | $393M | $407M | $415M | $419M | $422M | $412M | |
| Operating Expenses | $1.44B | $1.45B | $1.42B | $1.38B | $1.37B | $1.30B | $1.29B | $1.25B | $1.21B | $1.27B | $1.28B | $1.54B | $1.33B | $1.33B | $1.38B | $1.31B | |
| Operating Income | $399M | $353M | $443M | $360M | $300M | $376M | $408M | $333M | $363M | $384M | $408M | $133M | $383M | $426M | $471M | $411M | |
| Interest Expense | $25M | $25M | $27M | $28M | $29M | $28M | $32M | $22M | $20M | $22M | $22M | $24M | $24M | $25M | $23M | $19M | |
| Interest Income | $13M | $15M | $17M | $16M | $14M | $15M | $24M | $19M | $19M | $18M | $17M | $13M | $12M | $9M | $5M | $2M | |
| Other Non-op | $21M | $21M | $9M | $18M | $-25M | $4M | $1M | $13M | $12M | $23M | $17M | $10M | $6M | $0 | $2M | $3M | |
| Pretax Income | $408M | $364M | $442M | $366M | $260M | $367M | $401M | $343M | $374M | $403M | $420M | $132M | $377M | $410M | $455M | $397M | |
| Income Tax | $69M | $59M | $8M | $30M | $45M | $49M | $50M | $61M | $66M | $55M | $-55M | $21M | $75M | $58M | $87M | $68M | |
| Net Income | $339M | $305M | $434M | $336M | $215M | $318M | $351M | $282M | $308M | $348M | $475M | $111M | $302M | $352M | $368M | $329M | |
| EPS (Basic) | $1.20 | $1.08 | $1.54 | $1.18 | $0.75 | $1.12 | $1.23 | $0.97 | $1.05 | $1.19 | $1.63 | $0.38 | $1.02 | $1.19 | $1.23 | $1.10 | |
| EPS (Diluted) | $1.20 | $1.07 | $1.53 | $1.18 | $0.75 | $1.11 | $1.23 | $0.97 | $1.05 | $1.18 | $1.60 | $0.38 | $1.02 | $1.19 | $1.24 | $1.10 | |
| Shares (Basic) | 282,000,000 | 283,000,000 | -570,000,000 | 284,000,000 | 285,000,000 | 285,000,000 | -586,000,000 | 290,000,000 | 293,000,000 | 293,000,000 | -592,000,000 | 294,000,000 | 296,000,000 | 296,000,000 | -599,000,000 | 298,000,000 | |
| Shares (Diluted) | 283,000,000 | 284,000,000 | -572,000,000 | 285,000,000 | 285,000,000 | 287,000,000 | -587,000,000 | 291,000,000 | 293,000,000 | 294,000,000 | -593,000,000 | 295,000,000 | 297,000,000 | 297,000,000 | -603,000,000 | 299,000,000 | |
| EBITDA | $399M | $420M | · | $360M | $300M | $448M | · | $333M | $363M | $446M | · | $133M | $383M | $493M | · | $411M |
Balance Sheet 27
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.81B | $1.76B | $1.79B | $1.53B | $1.49B | $1.47B | $1.33B | $1.78B | $1.67B | $1.75B | $1.59B | $1.33B | $1.18B | $1.25B | $1.05B | $1.07B | |
| Receivables | $1.50B | $1.52B | $1.49B | $1.38B | $1.37B | $1.33B | $1.32B | $1.23B | $1.25B | $1.29B | · | $1.34B | $1.40B | $1.46B | · | $1.34B | |
| Inventory | $1.09B | $1.06B | $1.02B | $1.01B | $991M | $997M | $972M | $978M | $1.00B | $1.03B | · | $1.07B | $1.10B | $1.11B | · | $1.01B | |
| Other Current Assets | $369M | $277M | $293M | $322M | $365M | $315M | $334M | $272M | $283M | $262M | · | $290M | $270M | $258M | · | $258M | |
| Current Assets | $4.76B | $4.62B | $4.59B | $4.25B | $4.21B | $4.11B | $3.96B | $4.26B | $4.20B | $4.34B | · | $4.03B | $3.95B | $4.08B | · | $3.69B | |
| PP&E (Net) | $2.10B | $2.08B | $2.02B | $1.97B | $1.91B | $1.82B | $1.78B | $1.45B | $1.37B | $1.31B | · | $1.21B | $1.18B | $1.15B | · | $1.05B | |
| PP&E (Gross) | · | · | $3.45B | · | · | · | $3.08B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.42B | · | · | · | $1.30B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $4.48B | $4.48B | $4.47B | $4.47B | $4.47B | $4.43B | $4.48B | $3.96B | $3.96B | $3.97B | $3.96B | $3.98B | $3.98B | $3.98B | $3.95B | $3.95B | |
| Intangibles | $407M | $426M | $445M | $469M | $495M | $514M | $547M | $392M | $417M | $443M | · | $502M | $798M | $810M | · | $849M | |
| Other Non-current Assets | $1.18B | $1.07B | $1.06B | $930M | $934M | $875M | $910M | $751M | $725M | $716M | · | $758M | $695M | $713M | · | $749M | |
| Total Assets | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | · | $10.68B | $10.79B | $10.92B | · | $10.48B | |
| Accounts Payable | $615M | $602M | $570M | $530M | $517M | $547M | $540M | $497M | $461M | $488M | · | $452M | $479M | $540M | · | $558M | |
| Short-term Debt | $304M | $304M | $304M | $59M | $146M | $16M | $45M | $795M | $420M | · | · | $55M | $0 | $238M | · | $180M | |
| Current Liabilities | $2.27B | $2.23B | $2.35B | $1.89B | $2.01B | $1.87B | $1.90B | $2.39B | $1.96B | $1.62B | · | $1.76B | $1.67B | $1.94B | · | $1.90B | |
| Capital Leases | · | · | $145M | · | · | · | $142M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $496M | $491M | $463M | $495M | $535M | $551M | $578M | $471M | $449M | $486M | · | $531M | $515M | $542M | · | $583M | |
| Total Liabilities | $5.94B | $5.91B | $5.99B | $5.86B | $6.02B | $5.89B | $5.95B | $5.09B | $4.64B | $4.76B | · | $5.12B | $5.01B | $5.31B | · | $5.39B | |
| Long-term Debt | $3.05B | $3.05B | $3.05B | $3.35B | $3.35B | $3.35B | $3.35B | $2.14B | $2.14B | $2.56B | · | $2.73B | $2.73B | $2.73B | · | $2.73B | |
| Total Debt | $304M | $304M | · | $59M | $146M | $16M | · | $795M | $420M | · | · | $55M | $0 | $238M | · | $180M | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Paid-in Capital | $5.63B | $5.61B | $5.58B | $5.55B | $5.50B | $5.49B | $5.45B | $5.46B | $5.46B | $5.44B | · | $5.38B | $5.36B | $5.34B | · | $5.31B | |
| Retained Earnings | $1.69B | $1.48B | $1.39B | $1.10B | $912M | $916M | $750M | $773M | $1.09B | $1.06B | · | $444M | $700M | $541M | · | $139M | |
| AOCI | $-202M | $-184M | $-226M | $-283M | $-280M | $-381M | $-305M | $-331M | $-337M | $-316M | · | $-271M | $-282M | $-280M | $-347M | $-362M | |
| Stockholders' Equity | $7.12B | $6.91B | $6.74B | $6.37B | $6.14B | $6.03B | $5.90B | $5.90B | $6.21B | $6.19B | · | $5.56B | $5.78B | $5.61B | · | $5.09B | |
| Liabilities + Equity | $13.06B | $12.81B | $12.73B | $12.23B | $12.16B | $11.91B | $11.85B | $11.00B | $10.86B | $10.95B | · | $10.68B | $10.79B | $10.92B | · | $10.48B | |
| Shares Outstanding | 282,218,158 | 282,695,763 | 283,054,377 | 283,593,838 | 283,936,028 | 285,232,190 | 285,193,011 | 287,529,636 | 291,587,707 | 293,041,817 | · | 293,000,000 | 295,000,000 | 296,000,000 | · | 296,000,000 |
Cash Flow 19
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $67M | $67M | $71M | $72M | $73M | $72M | $69M | $63M | $63M | $62M | $62M | $71M | $71M | $67M | $73M | $80M | |
| Stock-based Comp | $32M | $41M | $26M | $32M | $30M | $40M | $26M | $28M | $31M | $44M | $14M | $29M | $24M | $44M | $26M | $28M | |
| Deferred Tax | $32M | $25M | $-95M | $-7M | $-18M | $-10M | $-56M | $-1M | $-7M | $0 | $13M | $-68M | $-5M | $4M | $-17M | $6M | |
| Amort. of Intangibles | $19M | $19M | $24M | $26M | $27M | $28M | $27M | $25M | $27M | $26M | $27M | $39M | $38M | $36M | $42M | $48M | |
| Restructuring | $8M | $20M | $8M | $17M | $56M | $1M | $5M | $67M | $1M | $3M | · | · | · | · | · | · | |
| Other Non-cash | · | $-170M | · | · | · | $11M | · | · | · | $31M | · | · | · | $-171M | · | · | |
| Operating Cash Flow | $277M | $268M | $545M | $362M | $221M | $431M | $481M | $452M | $333M | $485M | $516M | $562M | $398M | $296M | $448M | $326M | |
| CapEx | $76M | $93M | $93M | $103M | $114M | $97M | $93M | $92M | $103M | $90M | $84M | $81M | $57M | $76M | $70M | $82M | |
| Investing Cash Flow | $-77M | $-93M | $-90M | $-96M | $-114M | $-94M | $-954M | $-100M | $-109M | $-95M | $-40M | $-89M | $-77M | $-104M | $-110M | $-73M | |
| Debt Issued | $0 | $0 | $0 | $0 | $0 | $4M | $1.20B | $0 | $0 | $0 | $0 | · | · | · | $0 | · | |
| Net Debt Issued | · | $-2M | · | · | · | $3M | · | · | · | $-180M | · | · | · | · | · | · | |
| Stock Repurchased | $65M | $152M | $85M | $85M | $165M | $90M | $335M | $585M | $230M | $0 | $80M | $335M | $85M | $75M | $135M | $323M | |
| Net Stock Activity | · | $-152M | · | · | · | $-90M | · | · | · | $0 | · | · | · | $-75M | · | · | |
| Dividends Paid | $72M | $72M | $70M | $71M | $70M | $71M | $68M | $68M | $69M | $69M | $66M | $66M | $66M | $67M | $62M | $62M | |
| Financing Cash Flow | $-144M | $-222M | $-200M | $-219M | $-116M | $-180M | $25M | $-246M | $-291M | $-240M | $-201M | $-322M | $-390M | $-17M | $-341M | $-362M | |
| Net Change in Cash | $49M | $-31M | $254M | $48M | $19M | $138M | $-450M | $108M | $-76M | $157M | $261M | $154M | $-75M | $197M | $-17M | $-115M | |
| Taxes Paid | $215M | $105M | $14M | $56M | $229M | $19M | $30M | $60M | $200M | $24M | $56M | $15M | $111M | $17M | $62M | $83M | |
| Free Cash Flow | · | $175M | · | · | · | $334M | · | · | · | $395M | · | · | · | $220M | · | · | |
| Levered FCF | · | $154M | · | · | · | $310M | · | · | · | $376M | · | · | · | $199M | · | · |
Profitability 7
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 21.7% | 19.6% | · | 20.7% | 18.0% | 22.4% | · | 21.1% | 23.1% | 23.2% | · | 8.0% | 22.3% | 24.3% | · | 23.9% | |
| Net Margin | 18.5% | 17.0% | · | 19.3% | 12.9% | 18.9% | · | 17.9% | 19.6% | 21.0% | · | 6.6% | 17.6% | 20.1% | · | 19.1% | |
| Pretax Margin | 22.2% | 20.2% | · | 21.1% | 15.6% | 21.8% | · | 21.7% | 23.8% | 24.3% | · | 7.9% | 22.0% | 23.4% | · | 23.1% | |
| EBITDA Margin | 21.7% | 23.4% | · | 20.7% | 18.0% | 26.7% | · | 21.1% | 23.1% | 26.9% | · | 8.0% | 22.3% | 28.1% | · | 23.9% | |
| ROA | 2.7% | 2.5% | · | 2.9% | 1.9% | 2.8% | · | 2.6% | 2.9% | 3.2% | · | 1.1% | 2.8% | 3.3% | · | 3.1% | |
| ROE | 5.1% | 4.7% | · | 5.5% | 3.5% | 5.2% | · | 4.9% | 5.1% | 5.9% | · | 2.1% | 5.5% | 6.5% | · | 6.6% | |
| ROIC | 4.5% | 4.1% | · | 5.1% | 4.0% | 5.4% | · | 4.1% | 4.5% | 5.4% | · | 2.0% | 5.3% | 6.3% | · | 6.5% |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.1 | · | 2.2 | 2.1 | 2.2 | · | 1.8 | 2.1 | 2.7 | · | 2.3 | 2.4 | 2.1 | · | 1.9 | |
| Quick Ratio | 1.5 | 1.5 | · | 1.5 | 1.4 | 1.5 | · | 1.3 | 1.5 | 1.9 | · | 1.5 | 1.5 | 1.4 | · | 1.3 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | 16.0 | 14.1 | · | 12.9 | 10.3 | 13.4 | · | 15.1 | 18.1 | 17.5 | · | 5.5 | 16.0 | 17.0 | · | 21.6 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.7 | · | 1.0 | 0.8 | 0.8 | · | 0.9 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.3 | · | 1.4 |
Valuation (TTM) 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7.04B | $6.88B | · | $6.67B | $6.50B | $6.49B | · | $6.48B | $6.62B | $6.80B | · | $6.86B | $6.80B | $6.75B | · | $6.58B | |
| Net Income TTM | $1.20B | $1.17B | · | $1.15B | $1.12B | $1.26B | · | $1.05B | $1.07B | $1.11B | · | $1.09B | $1.26B | $1.24B | · | $1.15B | |
| Market Cap | $32.61B | $37.84B | · | $32.56B | $30.55B | $43.22B | · | $40.66B | $39.96B | $38.12B | · | $35.68B | $39.95B | $45.02B | · | $39.69B | |
| Enterprise Value | $31.11B | $36.38B | · | $31.08B | $29.21B | $41.77B | · | $39.67B | $38.71B | · | · | $34.40B | $38.78B | $44.00B | · | $38.80B | |
| P/E | 27.5 | 32.6 | · | 28.6 | 27.7 | 35.2 | · | 39.5 | 37.8 | 34.5 | · | 33.0 | 32.1 | 36.8 | · | 35.3 | |
| P/S | 4.6 | 5.5 | · | 4.9 | 4.7 | 6.7 | · | 6.3 | 6.0 | 5.6 | · | 5.2 | 5.9 | 6.7 | · | 6.0 | |
| P/B | 4.6 | 5.5 | · | 5.1 | 5.0 | 7.2 | · | 6.9 | 6.4 | 6.2 | · | 6.4 | 6.9 | 8.0 | · | 7.8 | |
| P / Tangible Book | 14.6 | 18.9 | · | 22.8 | 26.2 | 39.9 | · | 26.3 | 21.8 | 21.4 | · | 33.3 | 39.8 | 55.2 | · | 135.0 | |
| P / Cash Flow | · | 141.2 | · | · | · | 100.3 | · | · | · | 78.6 | · | · | · | 152.1 | · | · | |
| P / FCF | · | 216.2 | · | · | · | 129.4 | · | · | · | 96.5 | · | · | · | 204.6 | · | · | |
| EV / EBITDA | 78.0 | 86.6 | · | 86.3 | 97.4 | 93.2 | · | 119.1 | 106.6 | · | · | 258.7 | 101.2 | 89.3 | · | 94.4 | |
| EV / FCF | · | 207.9 | · | · | · | 125.1 | · | · | · | · | · | · | · | 200.0 | · | · | |
| EV / Revenue | 4.4 | 5.3 | · | 4.7 | 4.5 | 6.4 | · | 6.1 | 5.8 | · | · | 5.0 | 5.7 | 6.5 | · | 5.9 | |
| Dividend Yield | 0.87% | 0.75% | · | 0.86% | 0.91% | 0.64% | · | 0.67% | 0.68% | 0.70% | · | 0.73% | 0.65% | 0.57% | · | 0.62% | |
| Earnings Yield | 3.6% | 3.1% | · | 3.5% | 3.6% | 2.8% | · | 2.5% | 2.6% | 2.9% | · | 3.0% | 3.1% | 2.7% | · | 2.8% | |
| Payout Ratio | 21.2% | 23.6% | · | 21.1% | 32.6% | 22.3% | · | 24.1% | 22.4% | 19.8% | · | 59.5% | 21.9% | 19.0% | · | 18.8% | |
| Annual Payout | $285M | $284M | · | $280M | $278M | $277M | · | $272M | $270M | $268M | · | $261M | $258M | $255M | · | $247M |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Revenue | $6.95B | $6.51B | $6.83B | $6.85B | $6.32B |
| Operating Margin % | 21.3% | 22.9% | 19.8% | 23.6% | 21.3% |
| Net Income | $1.30B | $1.29B | $1.24B | $1.25B | $1.21B |
| Diluted EPS | $4.57 | $4.43 | $4.19 | $4.18 | $3.94 |
Balance Sheet
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| Current Ratio | 2.0 | 2.1 | 2.6 | 2.0 | 2.2 |
| Quick Ratio | 1.4 | 1.4 | 1.8 | 1.3 | 1.6 |
Cash Flow
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $1.15B | $1.37B | $1.47B | $1.02B | $1.30B |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 1,217 filers · $26.2B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 151 (+31 vs prior Q) | 76 (-76 vs prior Q) | 431 (+50 vs prior Q) | 339 (-36 vs prior Q) | +53.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $4,259,623,862 | 31,304,651 | 16.26% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $2,450,695,036 | 18,449,861 | 9.36% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,918,389,438 | 14,442,441 | 7.32% | Shares |
| STATE STREET CORP | $1,710,658,167 | 12,854,230 | 6.53% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $978,381,680 | 7,365,668 | 3.74% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $913,419,841 | 6,876,608 | 3.49% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $881,928,971 | 6,669,587 | 3.37% | Shares |
| Pictet Asset Management Holding SA | $596,979,330 | 4,494,311 | 2.28% | Shares |
| NORGES BANK | $513,991,530 | 3,869,544 | 1.96% | Shares |
| FMR LLC | $496,375,681 | 3,736,924 | 1.89% | Shares |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $367,735,737 | 2,768,469 | 1.40% | Shares |
| Troy Asset Management Ltd | $355,539,021 | 2,676,647 | 1.36% | Shares |
| GOLDMAN SACHS GROUP INC | $301,597,289 | 2,270,551 | 1.15% | Shares |
| FIRST TRUST ADVISORS LP | $276,230,248 | 2,079,578 | 1.05% | Shares |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $261,614,131 | 1,969,541 | 1.00% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $259,427,413 | 1,953,078 | 0.99% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $256,612,683 | 1,931,888 | 0.98% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $245,065,240 | 1,844,954 | 0.94% | Shares |
| Impax Asset Management Group plc | $222,484,548 | 1,674,957 | 0.85% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $210,722,973 | 1,586,411 | 0.80% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $192,780,430 | 1,451,332 | 0.74% | Shares |
| Qube Research & Technologies Ltd | $188,002,734 | 1,415,364 | 0.72% | Shares |
| Candriam S.C.A. | $179,443,631 | 1,352,228 | 0.69% | Shares |
| PRIMECAP MANAGEMENT CO/CA/ | $176,318,012 | 1,327,396 | 0.67% | Shares |
| Bank of New York Mellon Corp | $175,956,447 | 1,324,674 | 0.67% | Shares |
| Findlay Park Partners LLP | $174,281,328 | 1,312,063 | 0.67% | Shares |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $170,987,393 | 1,287,265 | 0.65% | Shares |
| VAN ECK ASSOCIATES CORP | $163,847,133 | 1,233,510 | 0.63% | Shares |
| CITADEL ADVISORS LLC | $141,805,854 | 1,067,574 | 0.54% | Shares |
| JUPITER ASSET MANAGEMENT LTD | $137,850,416 | 1,046,214 | 0.53% | Shares |
| Robeco Schweiz AG | $133,837,515 | 1,007,585 | 0.51% | Shares |
| TD Asset Management Inc | $132,416,102 | 996,884 | 0.51% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $125,377,572 | 943,900 | 0.48% | Shares |
| BlackRock, Inc. | $116,504,263 | 877,093 | 0.44% | Shares |
| Quantinno Capital Management LP | $115,638,237 | 870,573 | 0.44% | Shares |
| Alyeska Investment Group, L.P. | $108,252,598 | 814,971 | 0.41% | Shares |
| Swiss National Bank | $105,892,076 | 797,200 | 0.40% | Shares |
| Scharf Investments, LLC | $100,176,558 | 754,161 | 0.38% | Shares |
| Legal & General Group Plc | $98,122,318 | 738,706 | 0.37% | Shares |
| Liontrust Investment Partners LLP | $96,037,390 | 705,794 | 0.37% | Shares |
| M&G PLC | $95,397,309 | 717,273 | 0.36% | Shares |
| Madison Investment Advisors, LLC | $94,050,693 | 700,094 | 0.36% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $92,358,027 | 695,310 | 0.35% | Shares |
| Freestone Grove Partners LP | $91,081,398 | 685,699 | 0.35% | Shares |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $90,900,351 | 684,336 | 0.35% | Shares |
| SUMMITRY LLC | $88,508,881 | 666,332 | 0.34% | Shares |
| BANK OF AMERICA CORP /DE/ | $87,994,562 | 662,460 | 0.34% | Shares |
| AMERIPRISE FINANCIAL INC | $87,419,975 | 658,029 | 0.33% | Shares |
| ALLIANCEBERNSTEIN L.P. | $85,742,481 | 752,259 | 0.33% | Shares |
| LAZARD ASSET MANAGEMENT LLC | $85,180,425 | 641,274 | 0.33% | Shares |
| Madison Asset Management, LLC | $83,917,028 | 631,763 | 0.32% | Shares |
| JENNISON ASSOCIATES LLC | $82,524,356 | 621,278 | 0.32% | Shares |
| Sumitomo Mitsui Trust Group, Inc. | $81,741,191 | 615,382 | 0.31% | Shares |
| Vanguard Global Advisers, LLC | $80,906,886 | 609,101 | 0.31% | Shares |
| PARNASSUS INVESTMENTS, LLC | $80,640,827 | 607,098 | 0.31% | Shares |
| California Public Employees Retirement System | $79,884,892 | 601,407 | 0.30% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $75,494,859 | 568,162 | 0.29% | Shares |
| Fenimore Asset Management Inc | $74,567,504 | 561,375 | 0.28% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $72,868,280 | 548,583 | 0.28% | Shares |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $72,747,936 | 547,677 | 0.28% | Shares |
| Harvest Portfolios Group Inc. | $70,685,352 | 532,149 | 0.27% | Shares |
| JANE STREET GROUP, LLC | $69,842,014 | 525,800 | 0.27% | Put option |
| Select Equity Group, L.P. | $68,419,936 | 515,094 | 0.26% | Shares |
| RHUMBLINE ADVISERS | $66,522,113 | 500,807 | 0.25% | Shares |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $63,471,621 | 477,841 | 0.24% | Shares |
| National Pension Service | $62,363,818 | 469,501 | 0.24% | Shares |
| Squarepoint Ops LLC | $61,937,832 | 466,294 | 0.24% | Shares |
| BARCLAYS PLC | $61,183,224 | 460,613 | 0.23% | Shares |
| EARNEST PARTNERS LLC | $59,928,911 | 451,170 | 0.23% | Shares |
| BANK OF NOVA SCOTIA | $58,538,579 | 440,703 | 0.22% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $57,724,332 | 434,573 | 0.22% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $57,355,994 | 431,800 | 0.22% | Call option |
| DAVENPORT & Co LLC | $57,354,874 | 431,792 | 0.22% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $49,992,426 | 438,607 | 0.19% | Shares |
| D. E. Shaw & Co., Inc. | $47,442,758 | 357,169 | 0.18% | Shares |
| Susquehanna Portfolio Strategies, LLC | $46,586,802 | 350,725 | 0.18% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $43,801,225 | 329,754 | 0.17% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $43,116,220 | 324,597 | 0.16% | Shares |
| CITADEL ADVISORS LLC | $42,784,543 | 322,100 | 0.16% | Call option |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42,660,480 | 321,166 | 0.16% | Shares |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $41,663,724 | 313,662 | 0.16% | Shares |
| Swedbank AB | $39,972,666 | 300,931 | 0.15% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39,596,623 | 298,100 | 0.15% | Put option |
| Robeco Institutional Asset Management B.V. | $39,088,283 | 294,273 | 0.15% | Shares |
| Northwest & Ethical Investments L.P. | $35,746,445 | 269,114 | 0.14% | Shares |
| Gotham Asset Management, LLC | $34,062,261 | 256,435 | 0.13% | Shares |
| AVIVA PLC | $32,455,417 | 244,338 | 0.12% | Shares |
| Corient Private Wealth LP | $32,351,707 | 243,555 | 0.12% | Shares |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $31,475,662 | 236,962 | 0.12% | Shares |
| Aberdeen Group plc | $31,361,030 | 236,099 | 0.12% | Shares |
| Polar Capital Holdings Plc | $28,652,361 | 215,707 | 0.11% | Shares |
| ASSETMARK, INC | $28,532,974 | 214,808 | 0.11% | Shares |
| Eurizon Capital SGR S.p.A. | $27,472,791 | 206,818 | 0.10% | Shares |
| DANSKE BANK A/S | $26,955,989 | 202,936 | 0.10% | Shares |
| DKRT Investments Corp. | $26,566,000 | 200,000 | 0.10% | Shares |
| HSBC HOLDINGS PLC | $26,124,912 | 198,006 | 0.10% | Shares |
| ROYAL BANK OF CANADA | $25,054,000 | 188,614 | 0.10% | Shares |
| Epoch Investment Partners, Inc. | $24,780,233 | 186,556 | 0.09% | Shares |
| STRS OHIO | $24,668,258 | 185,713 | 0.09% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $24,547,914 | 184,807 | 0.09% | Shares |
Company insiders 65 insiders · 39 officers · 23 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| MCDONNELL PADRAIG | President and CEO | June 3, 2026 F | 65,842 | 0 | 3 | $-2,253,752 |
| Michael R. Mcmullen | CEO and President | March 8, 2024 S | 253,909 | 0 | 0 | $0 |
| William P Sullivan | CEO | Dec. 1, 2014 S | 458,167 | 0 | 0 | $0 |
| Adam Stewart Elinoff | Senior Vice President and CFO | Nov. 18, 2025 A | 11,726 | 0 | 0 | $0 |
| Robert W. Mcmahon | Sr. VP and CFO | May 22, 2025 F | 168,754 | 0 | 0 | $0 |
| Didier Hirsch | Sr. VP and CFO | Dec. 7, 2017 F | 184,432 | 0 | 0 | $0 |
| Adrian T Dillon | EVP, Finance & Admin., CFO | March 30, 2010 M | 129,925 | 0 | 0 | $0 |
| Jonah Prevost Kirkwood | Senior Vice President | June 26, 2026 F | 14,108 | 0 | 0 | $0 |
| Michael Steven Buckner | Senior Vice President | May 19, 2026 A | 8,887 | 0 | 0 | $0 |
| Simon May | Senior Vice President | May 8, 2026 F | 14,015 | 0 | 0 | $0 |
| Meghan Henson | Senior Vice President | March 31, 2026 F | 6,890 | 0 | 0 | $0 |
| Angelica Riemann | Senior Vice President | Feb. 27, 2026 F | 26,535 | 0 | 0 | $0 |
| Jianmiao Mike Zhang | Senior Vice President | Nov. 26, 2025 F | 11,639 | 0 | 0 | $0 |
| Rodney Gonsalves | V.P., Corporate Controller | Nov. 26, 2025 G | 0 | 0 | 1 | $-464,970 |
| Bret Dimarco | Senior Vice President | Nov. 26, 2025 F | 12,203 | 0 | 0 | $0 |
| Henrik Ancher-Jensen | Sr Vice President | May 30, 2025 F | 86,426 | 0 | 0 | $0 |
| Philip Binns | Senior Vice President | Nov. 19, 2024 A | 10,650 | 0 | 0 | $0 |
| Dominique Grau | Senior Vice President | Sept. 26, 2024 S | 46,762 | 0 | 0 | $0 |
| Michael Tang | SVP, General Counsel, and Sec. | Nov. 22, 2023 A | 54,872 | 0 | 0 | $0 |
| Samraat S. Raha | Sr. Vice President | Nov. 14, 2023 F | 87,196 | 0 | 0 | $0 |
| Jacob Thaysen | Sr. Vice President | Dec. 1, 2022 S | 84,464 | 0 | 0 | $0 |
| Mark Doak | Sr. Vice President | March 3, 2020 S | 135,678 | 0 | 0 | $0 |
| Patrick Kaltenbach | Sr Vice President | March 29, 2018 M | 68,547 | 0 | 0 | $0 |
| Marie Oh Huber | Sr VP, General Counsel & Sec. | March 3, 2015 M | 44,772 | 0 | 0 | $0 |
| Solange Glaize | VP, Chief Accounting Officer | Feb. 20, 2015 M | 5,370 | 0 | 0 | $0 |
| Fred Strohmeier | Senior Vice President | Nov. 19, 2014 A | 27,496 | 0 | 0 | $0 |
| Guy Sene | Senior Vice President | Sept. 2, 2014 M | 32,713 | 0 | 0 | $0 |
| Jean Halloran | Senior Vice President | June 17, 2014 M | 74,962 | 0 | 0 | $0 |
| Ronald S. Nersesian | Executive Vice President | Nov. 21, 2013 M | 102,821 | 0 | 0 | $0 |
| Lars Holmkvist | Senior Vice President | Nov. 20, 2013 A | — | 0 | 0 | $0 |
| Nicolas H Roelofs PHD | Senior Vice President | March 28, 2013 M | 84,136 | 0 | 0 | $0 |
| Saleem N. Odeh | Vice President | Nov. 18, 2009 A | 22,540 | 0 | 0 | $0 |
| Lonnie G. Justice | Vice President | Nov. 18, 2009 A | 32,742 | 0 | 0 | $0 |
| Soon Chai Gooi | Vice President | Nov. 18, 2009 A | 27,285 | 0 | 0 | $0 |
| David S Churchill | Vice President | Nov. 18, 2009 F | 25,602 | 0 | 0 | $0 |
| Chris Van Ingen | Senior Vice President | Oct. 31, 2007 J | 62,083 | 0 | 0 | $0 |
| Thomas White | Senior Vice President | April 28, 2006 A | 16,331 | 0 | 0 | $0 |
| Jack P Trautman | Senior Vice President | April 29, 2005 A | 12,343 | 0 | 0 | $0 |
| Dick M Chang | Senior Vice President | April 29, 2005 A | 7,174 | 0 | 0 | $0 |
| Mikael Dolsten | Director | May 29, 2026 S | 5,548 | 0 | 2 | $-606,178 |
| Pascal Soriot | Director | March 19, 2026 F | 2,683 | 0 | 0 | $0 |
| Mala Anand | Director | March 19, 2026 A | 16,705 | 0 | 0 | $0 |
| Daniel K Podolsky | Director | March 19, 2026 A | 38,180 | 0 | 0 | $0 |
| Sue H. Rataj | Director | March 19, 2026 A | 23,617 | 0 | 0 | $0 |
| Judy L Brown | Director | March 19, 2026 A | 3,835 | 0 | 0 | $0 |
| Dow R Wilson | Director | March 19, 2026 A | 20,369 | 0 | 0 | $0 |
| Boon Hwee Koh | Director | March 19, 2026 F | 63,184 | 0 | 0 | $0 |
| Otis W Brawley | Director | March 19, 2026 A | 13,874 | 0 | 0 | $0 |
| George A Scangos | Director | March 19, 2026 A | 23,857 | 0 | 0 | $0 |
| Heidi Kunz | Director | March 14, 2025 A | 58,851 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Agilent Technologies, Inc. | April 16, 2007 | — | Initial filing | M&A / sale | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 180 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PHO · Invesco Exchange-Traded Fund Trust | 3.90% | 559,512 SH | Aug. 8, 2026 | Daily |
| KAT · Advisors Series Trust | 3.04% | 179,660 NS | March 31, 2026 | N-PORT |
| GKAT · Advisors Series Trust | 3.00% | 39,208 NS | March 31, 2026 | N-PORT |
| PIO · Invesco Exchange-Traded Fund Trust … | 2.89% | 56,131 SH | Aug. 8, 2026 | Daily |
| GDOC · Goldman Sachs ETF Trust | 2.77% | 4,105 NS | May 31, 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 1.89% | 24,916 SH | Aug. 8, 2026 | Daily |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.68% | 90,084 SH | Aug. 8, 2026 | Daily |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.62% | 7,491 NS | April 30, 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 1.27% | 3,201 NS | May 31, 2026 | N-PORT |
| EPMB · Harbor ETF Trust | 1.18% | 461 NS | April 30, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.88% | 66,406 NS | April 30, 2026 | N-PORT |
| VOT · VANGUARD INDEX FUNDS | 0.82% | 2,162,223 SH | Aug. 8, 2026 | Daily |
| JOET · Virtus ETF Trust II | 0.79% | 16,177 NS | April 30, 2026 | N-PORT |
| IYH · iShares Trust | 0.65% | 169,194 SH | Aug. 8, 2026 | Daily |
| KRMA · Global X Funds | 0.58% | 5,164 NS | May 31, 2026 | N-PORT |
| LCLG · Advisors Series Trust | 0.57% | 5,020 NS | April 30, 2026 | N-PORT |
| RXL · ProShares Trust | 0.55% | 2,949 NS | May 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.55% | 849,670 SH | Aug. 8, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.53% | 130,688 NS | April 30, 2026 | N-PORT |
| GSY · Invesco Actively Managed Exchange-T… | 0.52% | 20,000,000 | Aug. 8, 2026 | Daily |
| IXJ · iShares Trust | 0.50% | 148,250 SH | Aug. 8, 2026 | Daily |
| NULC · Nushares ETF Trust | 0.50% | 2,455 NS | April 30, 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.47% | 5,640 NS | April 30, 2026 | N-PORT |
| WINN · Harbor ETF Trust | 0.44% | 41,201 NS | April 30, 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.40% | 11,883 NS | May 31, 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 0.39% | 1,301 NS | April 30, 2026 | N-PORT |
| IWS · iShares Trust | 0.38% | 426,163 SH | Aug. 8, 2026 | Daily |
| GNOM · Global X Funds | 0.38% | 1,553 NS | May 31, 2026 | N-PORT |
| ACGR · AMERICAN CENTURY ETF TRUST | 0.37% | 310 NS | May 31, 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.36% | 6,116,302 SH | Aug. 8, 2026 | Daily |
| SFGV · EA Series Trust | 0.34% | 28,465 NS | May 29, 2026 | N-PORT |
| ACLC · AMERICAN CENTURY ETF TRUST | 0.34% | 7,696 NS | May 31, 2026 | N-PORT |
| PEXL · Pacer Funds Trust | 0.31% | 1,211 NS | April 30, 2026 | N-PORT |
| IWR · iShares Trust | 0.29% | 1,149,977 SH | Aug. 8, 2026 | Daily |
| IMCV · iShares Trust | 0.28% | 23,013 SH | Aug. 8, 2026 | Daily |
| IMCB · iShares Trust | 0.27% | 32,787 SH | Aug. 8, 2026 | Daily |
| NUMV · Nushares ETF Trust | 0.27% | 10,213 NS | April 30, 2026 | N-PORT |
| SUSA · iShares Trust | 0.27% | 78,831 SH | Aug. 8, 2026 | Daily |
| IMCG · iShares Trust | 0.27% | 76,769 SH | Aug. 8, 2026 | Daily |
| DFLV · Dimensional ETF Trust | 0.25% | 129,056 NS | April 30, 2026 | N-PORT |
| SIZE · iShares Trust | 0.23% | 7,180 SH | Aug. 8, 2026 | Daily |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.23% | 8,663 NS | April 30, 2026 | N-PORT |
| EUSA · iShares, Inc. | 0.23% | 30,784 SH | Aug. 8, 2026 | Daily |
| XT · iShares Trust | 0.23% | 62,639 SH | Aug. 8, 2026 | Daily |
| GSEW · Goldman Sachs ETF Trust | 0.22% | 29,372 NS | May 31, 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.22% | 3,514 NS | May 31, 2026 | N-PORT |
| XOEF · iShares Trust | 0.22% | 355 SH | Aug. 8, 2026 | Daily |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 1,410,724 SH | Aug. 8, 2026 | Daily |
| NULV · Nushares ETF Trust | 0.19% | 34,471 NS | April 30, 2026 | N-PORT |
| SGLC · RBB Fund, Inc. | 0.19% | 2,753 NS | May 31, 2026 | N-PORT |